Nonetheless, even “leaky” CIITA defects ultimately result in significant immunodeficiency, and nearly all patients, whether harboring nonsense or missense variants, require aggressive supportive therapy and early consideration of curative hematopoietic stem-cell transplantation (HSCT) (32, 33). The gene discussed is CIITA; the disease is immune system disorder.